Combination therapy proves effective for patients with COPD

US-led researchers conducted two double-blind, 12-week studies each with around 1130 patients with moderate to severe COPD. 

They found that patients who were using the combination of indacaterol (Onbrez) and tiotropium (Spiriva) had at least 120mL more volume exhaled in FEV1 compared to patients on tiotropium alone, however they tended to develop more mild cough. 

“This single [publication] has shown that long-acting beta-agonists can be used with long-acting anticholinergic bronchodilators in patients with COPD,” said Associate Professor Ian Yang, consultant thoracic physician at the Prince